Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Curis LifesciencesNSE:CURIS -0.94%19 Pretax Margin % is 15.89% as of Mar. 2026, which is 8% below its 10-year median of 17.35. GuruFocus rates NSE:CURIS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 961 Drug Manufacturers companies, Curis Lifesciences ranks better than 72.63% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Curis Lifesciences Pretax Margin % Related Terms
Curis Lifesciences Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Curis Lifesciences's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis Lifesciences Pretax Margin % Chart
Curis Lifesciences Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Pretax Margin %
6.18
20.17
18.80
15.89
Curis Lifesciences Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
Pretax Margin %
6.18
20.17
18.80
15.89
NSE:CURIS vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Curis Lifesciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curis Lifesciences Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curis Lifesciences's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Curis Lifesciences's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis Lifesciences (NSE:CURIS) has a Pretax Margin % of 15.89% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Curis Lifesciences and its competitors. This is near median its historical median of 17.35. Over the past decade, Curis Lifesciences' Pretax Margin % has ranged from 6.18 to 20.17. According to the industry distribution chart, Curis Lifesciences ranks #263 out of 961 companies in the Drug Manufacturers industry, placing it in the top 27.4%.
Is Curis Lifesciences' Pretax Margin % too high?
Curis Lifesciences' current Pretax Margin % of 15.89% is near median its 10-year median of 17.35. Over the past 10 years, this metric has ranged from a low of 6.18 to a high of 20.17. The Drug Manufacturers industry median Pretax Margin % is 7.28. Curis Lifesciences' value of 15.89% is 118.3% above this industry median. Based on the distribution chart, Curis Lifesciences ranks #263 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Curis Lifesciences has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curis Lifesciences ranks #263 out of 961 companies for Pretax Margin %. This puts Curis Lifesciences in the upper half of its industry. The industry median Pretax Margin % is 7.28. Curis Lifesciences' value of 15.89% is 118.3% above this benchmark. Historically, Curis Lifesciences' own Pretax Margin % has ranged from 6.18 to 20.17 over the past decade. While the company's 10-year median is 17.35 vs. the industry median of 7.28, Curis Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curis Lifesciences's current Pretax Margin % of 15.89% is 118.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Curis Lifesciences and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curis Lifesciences's current Pretax Margin % is 15.89%, which is near median its own 10-year median of 17.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Pretax Margin % of 15.89%. The current Pretax Margin % is 15.89%, which is near median its 10-year median of 17.35 and 118.3% above the Drug Manufacturers industry median of 7.28. Curis Lifesciences' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Pretax Margin % is 15.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score
Get the complete analysis for NSE:CURIS
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CURIS has been successfully added to your 
